Globus Medical (GMED) Raw Materials (2018 - 2025)

Globus Medical (GMED) has reported Raw Materials for 8 consecutive years, with $152.1 million the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Raw Materials rose 31.33% year-over-year to $152.1 million; the trailing twelve-month figure through Sep 2025 stood at $152.1 million (up 31.33% YoY), and the FY2024 full-year result was $122.0 million, up 18.03% from the prior year.
• Raw Materials fell to $152.1 million in Q3 2025 per GMED's latest filing, from $153.3 million in the prior quarter.
• Across five years, Raw Materials topped out at $153.3 million in Q2 2025 and bottomed at $41.7 million in Q1 2021.
• Historically, Raw Materials has averaged $84.8 million across 5 years, with a median of $75.0 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Raw Materials climbed 5.48% in 2021, then soared 71.32% in 2023.
• Over 5 years, Raw Materials stood at $41.8 million in 2021, then jumped by 44.25% to $60.3 million in 2022, then jumped by 71.32% to $103.3 million in 2023, then gained by 18.03% to $122.0 million in 2024, then gained by 24.71% to $152.1 million in 2025.
• According to Business Quant data, Raw Materials over the past three periods registered $152.1 million, $153.3 million, and $118.6 million for Q3 2025, Q2 2025, and Q1 2025 respectively.